The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...
PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback